Evidence check: AMH in the context of longevity

The role of AMH (anti-Müllerian hormone) in longevity is not well-established. AMH is primarily a marker of ovarian reserve in women, declining with age. Some research suggests that higher AMH levels may be associated with later menopause, which could theoretically correlate with extended reproductive lifespan. However, direct evidence linking AMH to overall longevity or biological aging is limited and mostly observational. No robust biomarkers currently validate AMH as a predictor of life expectancy or healthy aging. Additionally, AMH's relevance in men is poorly understood. The provided context lacks specific information on AMH and longevity. Therefore, caution is warranted: an AMH test alone does not reliably indicate individual lifespan or aging rate. It should be interpreted as part of a broader hormonal and metabolic assessment, not as a standalone longevity marker.